Bactericidal activity of ramoplanin against antibiotic-resistant enterococci
- PMID: 1444316
- PMCID: PMC245501
- DOI: 10.1128/AAC.36.10.2342
Bactericidal activity of ramoplanin against antibiotic-resistant enterococci
Abstract
Ramoplanin, a new lipoglycodepsipeptide antibiotic, was uniformly active against 65 strains of enterococci, including strains highly resistant to vancomycin, penicillin G, and gentamicin. MBCs were usually within a fourfold dilution of the MICs. In time-kill studies, ramoplanin alone demonstrated dose-dependent bactericidal activity against enterococcal strains that resisted killing by vancomycin or penicillin in combination with gentamicin.
Similar articles
-
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.Diagn Microbiol Infect Dis. 1995 Jan;21(1):47-50. doi: 10.1016/0732-8893(94)00113-b. Diagn Microbiol Infect Dis. 1995. PMID: 7789096
-
In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.Antimicrob Agents Chemother. 1993 Jun;37(6):1364-6. doi: 10.1128/AAC.37.6.1364. Antimicrob Agents Chemother. 1993. PMID: 8328787 Free PMC article.
-
Treatment of experimental endocarditis caused by multidrug resistant Enterococcus faecium with ramoplanin and penicillin.J Antimicrob Chemother. 1996 Feb;37(2):323-9. doi: 10.1093/jac/37.2.323. J Antimicrob Chemother. 1996. PMID: 8707742
-
Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.J Antimicrob Chemother. 2003 Jun;51 Suppl 3:iii23-30. doi: 10.1093/jac/dkg273. J Antimicrob Chemother. 2003. PMID: 12801939 Review.
-
Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients.J Antimicrob Chemother. 2003 Jun;51 Suppl 3:iii31-5. doi: 10.1093/jac/dkg274. J Antimicrob Chemother. 2003. PMID: 12801940 Review.
Cited by
-
In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.Antimicrob Agents Chemother. 1993 Apr;37(4):896-900. doi: 10.1128/AAC.37.4.896. Antimicrob Agents Chemother. 1993. PMID: 8494388 Free PMC article.
-
Generation of ramoplanin-resistant Staphylococcus aureus.FEMS Microbiol Lett. 2010 Sep 1;310(2):104-11. doi: 10.1111/j.1574-6968.2010.02051.x. Epub 2010 Jul 2. FEMS Microbiol Lett. 2010. PMID: 20659164 Free PMC article.
-
Antimicrobial susceptibilities of enterococci isolated from hospitalized patients.Antimicrob Agents Chemother. 1993 May;37(5):1190-2. doi: 10.1128/AAC.37.5.1190. Antimicrob Agents Chemother. 1993. PMID: 8517714 Free PMC article.
-
Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria.Future Med Chem. 2013 Jul;5(11):1311-30. doi: 10.4155/fmc.13.86. Future Med Chem. 2013. PMID: 23859209 Free PMC article. Review.
-
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.Antimicrob Agents Chemother. 1996 Jun;40(6):1526-30. doi: 10.1128/AAC.40.6.1526. Antimicrob Agents Chemother. 1996. PMID: 8726031 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical